PCS-2023: 3E0M Introduction, Peritoneal Cavity

PCS-2023 > 3 > 3E > 3E0 > 3E0M

3E0	Physiological Systems and Anatomical Regions, Introduction
	Info:	Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
3E0M	Introduction, Peritoneal Cavity
3E0M0	Open
3E0M05	Adhesion Barrier
3E0M05Z	Introduction of Adhesion Barrier into Peritoneal Cavity, Open Approach
3E0M3	Percutaneous
3E0M30	Antineoplastic
3E0M304	Introduction of Liquid Brachytherapy Radioisotope into Peritoneal Cavity, Percutaneous Approach
3E0M305	Introduction of Other Antineoplastic into Peritoneal Cavity, Percutaneous Approach
3E0M30M	Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Percutaneous Approach
3E0M30Y	Introduction of Hyperthermic Antineoplastic into Peritoneal Cavity, Percutaneous Approach
3E0M32	Anti-infective
3E0M328	Introduction of Oxazolidinones into Peritoneal Cavity, Percutaneous Approach
3E0M329	Introduction of Other Anti-infective into Peritoneal Cavity, Percutaneous Approach
3E0M33	Anti-inflammatory
3E0M33Z	Introduction of Anti-inflammatory into Peritoneal Cavity, Percutaneous Approach
3E0M35	Adhesion Barrier
3E0M35Z	Introduction of Adhesion Barrier into Peritoneal Cavity, Percutaneous Approach
3E0M36	Nutritional Substance
3E0M36Z	Introduction of Nutritional Substance into Peritoneal Cavity, Percutaneous Approach
3E0M37	Electrolytic and Water Balance Substance
3E0M37Z	Introduction of Electrolytic and Water Balance Substance into Peritoneal Cavity, Percutaneous Approach
3E0M3B	Anesthetic Agent
3E0M3BZ	Introduction of Anesthetic Agent into Peritoneal Cavity, Percutaneous Approach
3E0M3H	Radioactive Substance
3E0M3HZ	Introduction of Radioactive Substance into Peritoneal Cavity, Percutaneous Approach
3E0M3K	Other Diagnostic Substance
3E0M3KZ	Introduction of Other Diagnostic Substance into Peritoneal Cavity, Percutaneous Approach
3E0M3N	Analgesics, Hypnotics, Sedatives
3E0M3NZ	Introduction of Analgesics, Hypnotics, Sedatives into Peritoneal Cavity, Percutaneous Approach
3E0M3T	Destructive Agent
3E0M3TZ	Introduction of Destructive Agent into Peritoneal Cavity, Percutaneous Approach
3E0M3G	Other Therapeutic Substance
3E0M3GC	Introduction of Other Therapeutic Substance into Peritoneal Cavity, Percutaneous Approach
3E0M3S	Gas
3E0M3SF	Introduction of Other Gas into Peritoneal Cavity, Percutaneous Approach
3E0M4	Percutaneous Endoscopic
3E0M45	Adhesion Barrier
3E0M45Z	Introduction of Adhesion Barrier into Peritoneal Cavity, Percutaneous Endoscopic Approach
3E0M4G	Other Therapeutic Substance
3E0M4GC	Introduction of Other Therapeutic Substance into Peritoneal Cavity, Percutaneous Endoscopic Approach
3E0M7	Via Natural or Artificial Opening
3E0M70	Antineoplastic
3E0M704	Introduction of Liquid Brachytherapy Radioisotope into Peritoneal Cavity, Via Natural or Artificial Opening
3E0M705	Introduction of Other Antineoplastic into Peritoneal Cavity, Via Natural or Artificial Opening
3E0M70M	Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Via Natural or Artificial Opening
3E0M7S	Gas
3E0M7SF	Introduction of Other Gas into Peritoneal Cavity, Via Natural or Artificial Opening

and

Physiological Systems and Anatomical Regions, Introduction

Introduction, Peritoneal Cavity